Celldex Therapeutics | CLDX - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 5.23B 400M 2025-12
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celldex Therapeutics USD 28.87M 7.17M 2025-12
Glaxosmithkline GBP 3.3B 303M 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Northwest Biotherapeutics USD 4.56M 244K 2025-09
Pfizer USD 1.34B 295M 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06